Vor Biopharma Inc. (VOR) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$142.71M | -43.2% |
| 2024 | -$99.66M | +0.6% |
| 2023 | -$100.29M | -17.8% |
| 2022 | -$85.14M | -23.1% |
| 2021 | -$69.14M | -90.5% |
| 2020 | -$36.29M | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$142.71M | -43.2% |
| 2024 | -$99.66M | +0.6% |
| 2023 | -$100.29M | -17.8% |
| 2022 | -$85.14M | -23.1% |
| 2021 | -$69.14M | -90.5% |
| 2020 | -$36.29M | — |